Related Experiment Videos
Transjugular renal biopsy. Our experience with 67 cases
I Rychlík1, J Petrtýl, V Tesar
11st Department of Medicine, 1st Faculty of Medicine, Charles University, Prague, Czech Republic. rychlik@cesnet.cz
Kidney & Blood Pressure Research
|August 31, 2001
Summary
Transjugular renal biopsy (TJRB) offers a vital alternative for patients with clotting disorders, enabling diagnosis of glomerulopathies when percutaneous biopsy is contraindicated. This novel technique provides an acceptable risk-benefit ratio when performed correctly.
Area of Science:
- Nephrology
- Interventional Radiology
- Pathology
Background:
- Transjugular renal biopsy (TJRB) is an emerging technique for renal tissue sampling via the transjugular route.
- It is particularly indicated for patients with clotting disorders where percutaneous biopsy is precluded.
- Limited studies have reported on larger patient experiences with TJRB.
Purpose of the Study:
- To analyze the authors' experience with transjugular renal biopsy.
- To evaluate the indications, diagnostic yield, and complications of TJRB.
- To assess the utility of TJRB in patients with contraindications for percutaneous biopsy.
Main Methods:
- A retrospective analysis of 67 patients who underwent TJRB between 1993 and 1999.
- Data collected included patient demographics, indications for biopsy, procedural details, histological findings, and complications.
- TJRB was often combined with liver biopsy or hepatic vein catheterization.
Main Results:
- Renal tissue was obtained in 79% of patients, with sufficient sample for diagnosis in 73%.
- Common indications included clotting disorders (39%) and combined kidney/liver biopsy needs (46%).
- Complication rate was 18% overall, significantly higher in patients with clotting disorders (34% vs. 7%).
Conclusions:
- TJRB is a valuable diagnostic tool for glomerulopathies, especially in patients with clotting disorders.
- The procedure facilitates diagnosis when percutaneous renal biopsy is not feasible.
- Proper technique is crucial for an acceptable risk-benefit ratio, with the procedure being well-tolerated.